Lower Risks of Gastrointestinal Perforation and Intestinal Obstruction in Patients with Atypical Antipsychotics in Comparison with Typical Antipsychotics Based on Real-World Data from the MID-NET® in Japan

The utilization and challenges of Japan's MID‐NET ® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies

(2019) Kaori Yamada et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

Establishment of the MID‐NET ® medical information database network as a reliable and valuable database for drug safety assessments in Japan

(2019) Mitsune Yamaguchi et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service

(2018) Ken Inada et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

(2017) Marco Solmi et al.   Therapeutics and Clinical Risk Management

Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia

(2016) T. Scott Stroup et al.   AMERICAN JOURNAL OF PSYCHIATRY

Psychotropic dose equivalence in Japan

(2015) Toshiya Inada et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Risk Factors for Ileus in Patients with Schizophrenia

(2010) J. Nielsen et al.   SCHIZOPHRENIA BULLETIN